文献速递生殖医学

高龄女性胚胎非整倍体植入前遗传学检测不影响三周期累计体外受精终止率

PGT for aneuploidy does not affect three-cycle cumulative IVF discontinuation rate in women of advanced maternal age.
PubMed 文献 · Reprod Biomed Online · 2019-03-12

在土耳其一家体外受精诊所进行的回顾性纵向队列研究纳入401例高龄连续病例,比较干预前常规体外受精(203对夫妇、270周期)与干预后行胚胎非整倍体植入前遗传学检测(198对夫妇、285周期)的终止率,结果显示两阶段完成三周期前的累计终止率相当,胚胎非整倍体植入前遗传学检测未降低终止率。

要点

  • 高龄女性未获持续妊娠者约90%在完成三周期体外受精前终止治疗。
  • 胚胎非整倍体植入前遗传学检测未降低累计终止率。
  • 女性年龄是终止治疗的唯一显著影响因素。

核心结论

  • 约90%未获持续妊娠的高龄病例在完成三周期体外受精前终止治疗,胚胎非整倍体植入前遗传学检测未降低终止率,女性衰老是唯一显著影响因素,女性年龄每增加1岁终止进一步体外受精治疗的风险比为1.07。

研究设计与样本

  • 回顾性纵向队列研究,在土耳其一家体外受精诊所开展,共纳入401例高龄连续病例;干预前为常规体外受精(2013年6月至2014年10月;203对夫妇;270周期),干预后为胚胎非整倍体植入前遗传学检测(2015年4月至2016年6月;198对夫妇;285周期)。
  • 主要结局指标为未获持续妊娠完成三周期体外受精治疗前的累计终止率,并通过电话调查明确终止原因。

主要发现

  • 第一周期和第二周期失败后的终止率两组相当,完成三周期前的累计终止率两组也相当。
  • 每胚胎移植的累计持续妊娠率在胚胎非整倍体植入前遗传学检测组显著更高(43.2% vs 16.8%;P < 0.001)。
  • 每患者的累计持续妊娠率两组相当(20.7% vs 16.3%)。
  • 女性年龄是终止治疗的唯一显著影响因素(风险比1.07;95% CI 1.09至1.13)。
  • 两组合计296对终止治疗的夫妇中,179对(179/296[60.5%])参与调查,心理负担是终止治疗的主要原因(37/179[20.7%])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does preimplantation genetic testing for aneuploidy (PGT-A) influence the discontinuation rate in women with advanced maternal age (AMA) undergoing IVF? DESIGN: Retrospective longitudinal cohort study carried out at a single IVF clinic in Turkey. In total, 401 consecutive AMA cases were included. Discontinuation rates of pre-intervention (conventional IVF; June 2013 to October 2014; 203 couples; 270 cycles) and post-intervention (PGT-A; April 2015 to June 2016; 198 couples; 285 cycles) periods were compared. To delineate the reason for discontinuation, a telephone survey was conducted. Primary outcome measure was cumulative discontinuation rate before completing three cycles of IVF treatment without achieving an ongoing pregnancy. RESULTS: The discontinuation rates after the first and second failed cycles were comparable between the two arms as were the cumulative discontinuation rates before completing three cycles. The cumulative ongoing pregnancy rate per embryo transfer was significantly higher in the PGT-A arm (43.2% versus 16.8%; P < 0.001). The cumulative ongoing pregnancy rate per patient was comparable between the two arms (20.7% versus 16.3%, respectively). Female age was the only significant contributor to treatment discontinuation (hazard ratio [HR] 1.07; 95% CI 1.09 to 1.13). Of the 296 couples discontinuing treatment in both arms, 179 (179/296 [60.5%]) participated in the survey; overall, psychological burden was the main reason for treatment discontinuation (37/179 [20.7%]). CONCLUSIONS: About 90% of AMA cases not achieving an ongoing pregnancy discontinue IVF treatment before completing three cycles. Discontinuation rate is not reduced by carrying out PGT-A. Female ageing is the only significant contributor, with a hazard of discontinuing further IVF treatment of 7% with female ageing of 1-year.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Mumusoglu S, Ozbek IY, Coskun ZY, et al. PGT for aneuploidy does not affect three-cycle cumulative IVF discontinuation rate in women of advanced maternal age. Reprod Biomed Online. 2019. PMID: 31047828. doi:10.1016/j.rbmo.2019.03.103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。